Paul Radensky
Subscribe to Paul Radensky's PostsPaul is a Medicare law and policy authority who is board-certified in internal medicine and who helps clients navigate federal legislative and regulatory processes related to Medicare coverage, coding, reimbursement and compliance as well as regulatory and promotional compliance matters with the Food and Drug Administration. Read Paul Radensky's full bio.
Medicare Coverage of Wegovy Raises Questions Regarding the Affordability and Accessibility of Novel Medications
By Jeffrey Davis, Paul Radensky, Parashar Patel and Amy Kelbick on May 15, 2024
Posted In Employee Benefits, Health and Welfare Plans
The Centers for Medicare & Medicaid Services (CMS) announced in March that it would allow health plans under Medicare Part D (the Medicare prescription drug benefit) to cover Wegovy and other weight-loss medications if they receive Food and Drug Administration (FDA) approval for an additional medically accepted indication. In Wegovy’s case, the FDA recently approved an additional...
Continue Reading
